Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician. - Abstract - Europe PMC
Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement | Mount Sinai - New York
Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | SpringerLink
PDF) LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: Results from the "LOWERING-IT" Trial
Optimal Intensity of Warfarin Therapy in Patients With Mechanical Aortic Valves | Semantic Scholar
what's you target INR ? | Heart Valve Replacement Forums
83 Valvular heart disease, anticoagulation, TAVR, and primary care - The Curbsiders
Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve -
Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario | SpringerLink
Antithrombotics — HaemBase
Antithrombotic Therapy in Patients With Valvular Heart Disease
INR follow-up after mechanical valve replacement | Download Scientific Diagram
Chris McAloon on Twitter: "ESC 2012 Guidelines on Target INR for Mechanical Valves (note types of valve & risk factors) #CardioEd #EEGC https://t.co/wpbVk30frW https://t.co/NqUjRIqdVu" / Twitter